2016
Changes in body composition in women using long-acting reversible contraception
dos Santos P, Madden T, Omvig K, Peipert J. Changes in body composition in women using long-acting reversible contraception. Contraception 2016, 95: 382-389. PMID: 28041992, PMCID: PMC5376505, DOI: 10.1016/j.contraception.2016.12.006.Peer-Reviewed Original ResearchConceptsENG implant usersCopper IUD usersLNG-IUSBody compositionBody weightIUD usersCopper IUDImplant usersWeight gainProspective cohort studyLevonorgestrel intrauterine systemSubgroup of womenBody composition changesLean body massLNG-IUS usersCopper intrauterine deviceContraceptive CHOICE ProjectBody massCohort studyENG implantHealthy womenIntrauterine systemMean ageBlack raceInclusion criteria
2013
Characteristics Associated With Discontinuation of Long-Acting Reversible Contraception Within the First 6 Months of Use
Grunloh D, Casner T, Secura G, Peipert J, Madden T. Characteristics Associated With Discontinuation of Long-Acting Reversible Contraception Within the First 6 Months of Use. Obstetrics And Gynecology 2013, 122: 1214-1221. PMID: 24201685, PMCID: PMC4051392, DOI: 10.1097/01.aog.0000435452.86108.59.Peer-Reviewed Original ResearchConceptsLevonorgestrel intrauterine systemIntrauterine deviceEarly discontinuationCopper intrauterine deviceBaseline characteristicsIntrauterine systemReversible contraceptionFirst-line contraceptive optionRate of discontinuationLong-Acting Reversible ContraceptionLow socioeconomic statusContraceptive CHOICE ProjectMonths of useCohort studyDiscontinuation ratesContraceptive optionsUnintended pregnancyFrequent bleedingDiscontinuationIUD usersCost contraceptionCommon reasonYounger ageLogistic regressionTelephone interviews
2011
Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial
Madden T, Proehl S, Allsworth J, Secura G, Peipert J. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. American Journal Of Obstetrics And Gynecology 2011, 206: 129.e1-129.e8. PMID: 22055339, PMCID: PMC3268863, DOI: 10.1016/j.ajog.2011.09.021.Peer-Reviewed Original ResearchConceptsNaproxen groupIntrauterine systemLevonorgestrel-releasing intrauterine system useLevonorgestrel-releasing intrauterine systemAdministration of naproxenLevonorgestrel intrauterine systemIntrauterine system useOral naproxenEstradiol groupTreat analysisMultivariable analysisLowest quartileFrequent bleedingPlaceboEstradiol decreaseEstradiolTrialsWomenNaproxenDaysGroupBleedingQuartileAdministrationWeeksContinuation and Satisfaction of Reversible Contraception
Peipert J, Zhao Q, Allsworth J, Petrosky E, Madden T, Eisenberg D, Secura G. Continuation and Satisfaction of Reversible Contraception. Obstetrics And Gynecology 2011, 117: 1105-1113. PMID: 21508749, PMCID: PMC3548669, DOI: 10.1097/aog.0b013e31821188ad.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildContraceptionContraceptive Agents, FemaleContraceptive Devices, FemaleContraceptives, OralFemaleFollow-Up StudiesHumansIntrauterine DevicesKaplan-Meier EstimateMiddle AgedPatient SatisfactionProportional Hazards ModelsProspective StudiesTime FactorsTransdermal PatchYoung AdultConceptsOral contraceptive pillsIntrauterine deviceReversible contraception methodsContinuation ratesReversible contraceptionContraception methodsContraceptive methodsFirst-line contraceptive methodReversible contraception usersProspective cohort studyHigh contraceptive efficacyMonths of enrollmentDepot medroxyprogesterone acetateLevonorgestrel intrauterine systemCopper intrauterine deviceContraceptive CHOICE ProjectHigh rateSurvey time pointsCohort studyIntrauterine systemContraceptive pillsMedroxyprogesterone acetateOCP usersContraceptive efficacyHormonal methods